These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1412 related items for PubMed ID: 19226280

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 4. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, Bieber T, Thomas WR, Valenta R, Zuberbier T, Sager A, Novak N.
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
    Maestrelli P, Zanolla L, Pozzan M, Fabbri LM, Regione Veneto Study Group on the "Effect of immunotherapy in allergic asthma".
    J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D, Keck T, Riechelmann H.
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
    Riechelmann H, Schmutzhard J, van der Werf JF, Distler A, Kleinjans HA.
    Am J Rhinol Allergy; 2010 Apr; 24(5):e104-9. PubMed ID: 21244725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
    Srivastava D, Singh BP, Sudha VT, Arora N, Gaur SN.
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA, Lutter R, van Ree R, van der Zee JS.
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [Abstract] [Full Text] [Related]

  • 13. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study.
    Klimek L, Willers J, Hammann-Haenni A, Pfaar O, Stocker H, Mueller P, Renner WA, Bachmann MF.
    Clin Exp Allergy; 2011 Sep; 41(9):1305-12. PubMed ID: 21672053
    [Abstract] [Full Text] [Related]

  • 14. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB.
    Int Arch Allergy Immunol; 2012 Sep; 157(3):288-98. PubMed ID: 22041501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S.
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C, Yazi D, Gocmen I, Yesil O, Aydogan M, Semic-Jusufagic A, Bahceciler NN, Barlan IB.
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D, Misirligil Z, Gürbüz L.
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.